Build Back Better, ACA and Drug Pricing on Kaiser Health News’ What the Health?
ACHP’s Ceci Connolly discusses the Build Back Better Act, ACA enrollment, drug pricing and more on KHN’s What the Health? podcast.
ACHP’s Ceci Connolly discusses the Build Back Better Act, ACA enrollment, drug pricing and more on KHN’s What the Health? podcast.
Besides being outrageously priced, Aduhelm is an unproven, potentially dangerous drug—a drug Medicare simply should not cover.
To improve health equity, UCare is leading the charge to collect more complete and accurate REaL data in the communities it serves
ACHP has provided feedback to CMS on the challenges created by requiring health plans to cover at-home COVID-19 testing.
ACHP and leading health care stakeholders partner to host value week on key legislative and regulatory value-based health care priorities.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.